Wuli Zhao

1.7k total citations
52 papers, 1.2k citations indexed

About

Wuli Zhao is a scholar working on Molecular Biology, Cell Biology and Pharmacology. According to data from OpenAlex, Wuli Zhao has authored 52 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 35 papers in Molecular Biology, 15 papers in Cell Biology and 14 papers in Pharmacology. Recurrent topics in Wuli Zhao's work include Microbial Natural Products and Biosynthesis (9 papers), Hippo pathway signaling and YAP/TAZ (9 papers) and Cancer therapeutics and mechanisms (6 papers). Wuli Zhao is often cited by papers focused on Microbial Natural Products and Biosynthesis (9 papers), Hippo pathway signaling and YAP/TAZ (9 papers) and Cancer therapeutics and mechanisms (6 papers). Wuli Zhao collaborates with scholars based in China, United Kingdom and Canada. Wuli Zhao's co-authors include Rong‐Guang Shao, Hongwei He, Cong-Hui Zhang, Cai‐Xia Zhang, Yuhan Qiu, Hong Liu, Yan Ma, Dongke Yu, Mengyan Wang and Tianshu Zhang and has published in prestigious journals such as Biochemical and Biophysical Research Communications, FEBS Letters and Small.

In The Last Decade

Wuli Zhao

52 papers receiving 1.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Wuli Zhao China 22 658 206 186 167 159 52 1.2k
Yohei Saito Japan 21 632 1.0× 214 1.0× 103 0.6× 120 0.7× 151 0.9× 82 1.2k
Prasanthi Karna United States 16 629 1.0× 214 1.0× 94 0.5× 73 0.4× 255 1.6× 21 1.2k
Linda Rickardson Sweden 18 705 1.1× 290 1.4× 103 0.6× 57 0.3× 219 1.4× 28 1.1k
Martin C. Sadowski Australia 20 707 1.1× 240 1.2× 125 0.7× 50 0.3× 298 1.9× 41 1.1k
Chia‐Liang Lin Taiwan 27 986 1.5× 152 0.7× 73 0.4× 122 0.7× 245 1.5× 67 1.7k
Bainan Wu United States 22 880 1.3× 244 1.2× 87 0.5× 102 0.6× 63 0.4× 28 1.2k
Maria Hägg Olofsson Sweden 17 1.2k 1.8× 472 2.3× 197 1.1× 40 0.2× 247 1.6× 26 1.7k
Eunice EunKyeong Kim South Korea 23 1.1k 1.7× 281 1.4× 201 1.1× 48 0.3× 166 1.0× 84 1.5k
Raghavendra Gowda United States 20 695 1.1× 248 1.2× 84 0.5× 56 0.3× 211 1.3× 37 1.2k
Gelina S. Kopeina Russia 21 1000 1.5× 285 1.4× 96 0.5× 39 0.2× 184 1.2× 59 1.4k

Countries citing papers authored by Wuli Zhao

Since Specialization
Citations

This map shows the geographic impact of Wuli Zhao's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Wuli Zhao with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Wuli Zhao more than expected).

Fields of papers citing papers by Wuli Zhao

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Wuli Zhao. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Wuli Zhao. The network helps show where Wuli Zhao may publish in the future.

Co-authorship network of co-authors of Wuli Zhao

This figure shows the co-authorship network connecting the top 25 collaborators of Wuli Zhao. A scholar is included among the top collaborators of Wuli Zhao based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Wuli Zhao. Wuli Zhao is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Zhao, Wuli, et al.. (2024). Anti-Tumor Potential of Post-Translational Modifications of PD-1. Current Issues in Molecular Biology. 46(3). 2119–2132. 2 indexed citations
3.
Yang, Bo, Wuli Zhao, Yingjie Ji, et al.. (2023). Design, synthesis and biological evaluation of 2-((4-sulfamoylphenyl)amino)-pyrrolo[2,3-d]pyrimidine derivatives as CDK inhibitors. Journal of Enzyme Inhibition and Medicinal Chemistry. 38(1). 2169282–2169282. 12 indexed citations
4.
Zhang, Jing, et al.. (2023). A Mitochondrial Perspective on Noncommunicable Diseases. Biomedicines. 11(3). 647–647. 5 indexed citations
5.
Chang, Shanshan, Yu‐Chuan Chen, Wuli Zhao, et al.. (2023). Cytotoxic hexadepsipeptides and anti-coronaviral 4-hydroxy-2-pyridones from an endophytic Fusarium sp.. Frontiers in Chemistry. 10. 1106869–1106869. 4 indexed citations
6.
Zhou, Huimin, Cong Zhao, Rong‐Guang Shao, Yanni Xu, & Wuli Zhao. (2023). The functions and regulatory pathways of S100A8/A9 and its receptors in cancers. Frontiers in Pharmacology. 14. 1187741–1187741. 30 indexed citations
7.
8.
Wang, Junxia, Minghua Chen, Wenxia Zhao, et al.. (2021). The novel ER stress inducer Sec C triggers apoptosis by sulfating ER cysteine residues and degrading YAP via ER stress in pancreatic cancer cells. Acta Pharmaceutica Sinica B. 12(1). 210–227. 23 indexed citations
9.
Zhang, Dewu, Xiaoyu Tao, Guowei Gu, et al.. (2021). Microbial Transformation of neo-Clerodane Diterpenoid, Scutebarbatine F, by Streptomyces sp. CPCC 205437. Frontiers in Microbiology. 12. 662321–662321. 5 indexed citations
10.
Wang, Xiaowei, Yuhan Qiu, Mengyan Wang, et al.. (2020). <p>Endocytosis and Organelle Targeting of Nanomedicines in Cancer Therapy</p>. International Journal of Nanomedicine. Volume 15. 9447–9467. 92 indexed citations
11.
Wang, Meng‐Yan, Cong-Hui Zhang, Junxia Wang, et al.. (2019). Role of co- and post-translational modifications of SFKs in their kinase activation. Journal of drug targeting. 28(1). 23–32. 1 indexed citations
12.
Zhao, Wuli, Hong Liu, Junxia Wang, Mengyan Wang, & Rong‐Guang Shao. (2018). Cyclizing-berberine A35 induces G2/M arrest and apoptosis by activating YAP phosphorylation (Ser127). Journal of Experimental & Clinical Cancer Research. 37(1). 98–98. 27 indexed citations
13.
Zhao, Shuangshuang, Wuli Zhao, Mao‐xu Ge, et al.. (2017). D-chiro-inositol effectively attenuates cholestasis in bile duct ligated rats by improving bile acid secretion and attenuating oxidative stress. Acta Pharmacologica Sinica. 39(2). 213–221. 24 indexed citations
14.
Liu, Hong, et al.. (2017). EBP50 suppresses the proliferation of MCF-7 human breast cancer cells via promoting Beclin-1/p62-mediated lysosomal degradation of c-Myc. Acta Pharmacologica Sinica. 39(8). 1347–1358. 10 indexed citations
15.
Chen, Yi, Dongke Yu, Caixia Zhang, et al.. (2013). Lidamycin inhibits tumor initiating cells of hepatocellular carcinoma Huh7 through GSK3β/β‐catenin pathway. Molecular Carcinogenesis. 54(1). 1–8. 19 indexed citations
16.
Zhao, Wuli, Yanxiang Wang, Cai‐Xia Zhang, et al.. (2013). Discovery, synthesis and biological evaluation of cycloprotoberberine derivatives as potential antitumor agents. European Journal of Medicinal Chemistry. 68. 463–472. 22 indexed citations
17.
Wang, Yanxiang, et al.. (2012). [Synthesis and structure-activity relationship of N-(2-arylethyl) isoquinoline derivatives as anti-cancer agents].. PubMed. 47(2). 200–5. 1 indexed citations
18.
Zhang, Hao, Shenghua Zhang, Hongwei He, et al.. (2012). GAP161 targets and downregulates G3BP to suppress cell growth and potentiate cisplaitin‐mediated cytotoxicity to colon carcinoma HCT116 cells. Cancer Science. 103(10). 1848–1856. 48 indexed citations
19.
Chen, Yi, Dongke Yu, Hao Zhang, et al.. (2012). CD133+EpCAM+ Phenotype Possesses More Characteristics of Tumor Initiating Cells in Hepatocellular Carcinoma Huh7 Cells. International Journal of Biological Sciences. 8(7). 992–1004. 84 indexed citations
20.
Li, Xin, Wuli Zhao, Jian‐Dong Jiang, et al.. (2011). Synthesis, structure–activity relationship and biological evaluation of anticancer activity for novel N-substituted sophoridinic acid derivatives. Bioorganic & Medicinal Chemistry Letters. 21(18). 5251–5254. 27 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Yohei Saito Breakdown of academic impact, for papers by Prasanthi Karna Breakdown of academic impact, for papers by Linda Rickardson Breakdown of academic impact, for papers by Martin C. Sadowski Breakdown of academic impact, for papers by Chia‐Liang Lin Breakdown of academic impact, for papers by Bainan Wu Breakdown of academic impact, for papers by Maria Hägg Olofsson Breakdown of academic impact, for papers by Eunice EunKyeong Kim Breakdown of academic impact, for papers by Raghavendra Gowda Breakdown of academic impact, for papers by Gelina S. Kopeina
Rankless by CCL
2026